Prognostic significance of subclassifying pathological T3 upper tract urothelial carcinoma: Results from a multicenter cohort study

被引:5
|
作者
Suhara, Yushi [1 ]
Urabe, Fumihiko [1 ]
Yoshihara, Kentaro [1 ,2 ]
Kurawaki, Shiro [1 ]
Fukuokaya, Wataru [1 ]
Iwatani, Kosuke [1 ,3 ]
Imai, Yu [1 ]
Sakanaka, Keigo [1 ]
Hisakane, Akira [1 ]
Kurauchi, Takashi [1 ]
Kayano, Sotaro [1 ]
Onuma, Hajime [1 ]
Mori, Keiichiro [1 ]
Kimura, Shoji [1 ]
Tashiro, Kojiro [1 ,2 ]
Tsuzuki, Shunsuke [1 ]
Miki, Jun [1 ,3 ]
Sato, Shun [4 ]
Takahashi, Hiroyuki [4 ]
Kimura, Takahiro [1 ]
机构
[1] Jikei Univ, Sch Med, Dept Urol, Tokyo, Japan
[2] Jikei Katsushika Med Ctr, Dept Urol, Tokyo, Japan
[3] Jikei Univ, Kashiwa Hosp, Dept Urol, Chiba, Japan
[4] Jikei Univ, Sch Med, Dept Pathol, Tokyo, Japan
关键词
pathological T3; subclassification of pT3; upper tract urothelial carcinoma; PREDICTIVE TOOLS; SUBCLASSIFICATION;
D O I
10.1111/iju.15321
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective: The population with pathological T3 (pT3) upper tract urothelial carcinoma (UTUC) is heterogeneous, thereby making prognostication challenging. We assessed the clinical ramifications of subclassifying pT3 UTUC after nephroureterectomy.Methods: We conducted a retrospective analysis including 308 patients who underwent nephroureterectomy for pT3N0-1M0 UTUC. pT3 was subclassified into pT3a and pT3b based on invasion of the peripelvic and/or periureteral fat. Cox's proportional hazard models were utilized to determine the significant prognosticators of oncological outcomes, encompassing intravesical recurrence-free survival, recurrence-free survival (RFS), cancer-specific survival (CSS), and overall survival.Results: Multivariate analysis elucidated that pT3b status, pathological N1 status, and lymphovascular invasion status were independent risk factors for an unfavorable RFS and CSS. Although the RFS and CSS of patients with pT3b UTUC were superior to those in patients with pT4 UTUC, no significant disparities were detected between patients with pT3a and pT2.Conclusion: Our findings demonstrate that pT3 UTUC with peripelvic/periureteral fat invasion is independently associated with metastasis and cancer-specific death after nephroureterectomy. These findings provide patients and physicians with invaluable insight into the risk for disease progression in pT3 UTUC patients.
引用
收藏
页码:125 / 132
页数:8
相关论文
共 50 条
  • [1] Editorial Comment to Prognostic significance of subclassifying pathological T3 upper tract urothelial carcinoma: Results from a multicenter cohort study
    Kondo, Tsunenori
    INTERNATIONAL JOURNAL OF UROLOGY, 2023,
  • [2] Predicting pathological upstaging after radical nephroureterectomy in patients with upper tract urothelial carcinoma: results from a multicenter cohort study
    Yamaguchi, Ryotaro
    Kagawa, Hirokazu
    Yoshihara, Kentaro
    Yamamoto, Shutaro
    Hara, Shuhei
    Miyajima, Keiichiro
    Enei, Yuki
    Fukuokaya, Wataru
    Iwatani, Kosuke
    Imai, Yu
    Atsuta, Mahito
    Mori, Keiichiro
    Igarashi, Taro
    Aikawa, Koichi
    Yanagisawa, Takafumi
    Kimura, Shoji
    Tashiro, Kojiro
    Tsuzuki, Shunsuke
    Ishii, Gen
    Higuchi, Takahiro
    Sato, Shun
    Yamada, Yuta
    Furuta, Akira
    Shimomura, Tatsuya
    Kimura, Takahiro
    Miki, Jun
    Urabe, Fumihiko
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2024, 13 (11)
  • [3] Prognostic value of prior history of urothelial carcinoma of the bladder in patients with upper urinary tract urothelial carcinoma: results from a retrospective multicenter study
    Nuhn, Philipp
    Novara, Giacomo
    Seitz, Christian
    Gupta, Amit
    Matsumoto, Kazumasa
    Kassouf, Wassim
    Walton, Thomas J.
    Fritsche, Hans-Martin
    Tritschler, Stefan
    Martinez-Salamanca, Juan I.
    Ficarra, Vincenzo
    Karakiewicz, Pierre I.
    Mazzoleni, Guido
    Shariat, Shahrokh F.
    Bastian, Patrick J.
    WORLD JOURNAL OF UROLOGY, 2015, 33 (07) : 1005 - 1013
  • [4] Prognostic value of prior history of urothelial carcinoma of the bladder in patients with upper urinary tract urothelial carcinoma: results from a retrospective multicenter study
    Philipp Nuhn
    Giacomo Novara
    Christian Seitz
    Amit Gupta
    Kazumasa Matsumoto
    Wassim Kassouf
    Thomas J. Walton
    Hans-Martin Fritsche
    Stefan Tritschler
    Juan I. Martínez-Salamanca
    Vincenzo Ficarra
    Pierre I. Karakiewicz
    Guido Mazzoleni
    Shahrokh F. Shariat
    Patrick J. Bastian
    World Journal of Urology, 2015, 33 : 1005 - 1013
  • [5] Prognostic microRNAs in upper tract urothelial carcinoma: multicenter and international validation study
    Izquierdo, Laura
    Montalbo, Ruth
    Ingelmo-Torres, Mercedes
    Mallofre, Carme
    Ramirez-Backhaus, Miguel
    Rubio, Jose
    Van der Heijden, Antoine G.
    Schaafsma, Ewout
    Lopez-Beltran, Antonio
    Blanca, Ana
    Lawrentschuk, Nathan
    Alcaraz, Antonio
    Mengual, Lourdes
    ONCOTARGET, 2017, 8 (31) : 51522 - 51529
  • [6] PROGNOSTIC SIGNIFICANCE OF TUMOR LOCATION IN UPPER TRACT UROTHELIAL CARCINOMA
    Yafi, Faysal A.
    Shariat, Shahrokh F.
    Novara, Giacomo
    Gupta, Amit
    Matsumoto, Kazumasa
    Walton, Thomas J.
    Fritsche, Hans-Martin
    Bastian, Patrick J.
    Martinez-Salamanca, Juan I.
    Seitz, Christian
    Ficarra, Vincenzo
    Karakiewicz, Pierre I.
    Kassouf, Wassim
    JOURNAL OF UROLOGY, 2010, 183 (04): : E165 - E165
  • [7] Pathological significance and prognostic utility of KIBRA in upper urinary tract urothelial cancer
    Kondo, T.
    Miyata, Y.
    Matsuda, T.
    Harada, J.
    Mukae, Y.
    Ohtsubo, A.
    Mitsunari, K.
    Matsuo, T.
    Ohba, K.
    Sakai, H.
    EUROPEAN UROLOGY, 2021, 79 : S1087 - S1087
  • [8] Prognostic significance of tumor multifocality on outcomes in patients with upper tract urothelial carcinoma after radical nephroureterectomy: A cohort study
    Milojevic, Bogomir
    Bumbasirevic, Uros
    Santric, Veljko
    Kajmakovic, Boris
    Dragicevic, Dejan
    Radisavcevic, Djordje
    Sretenovic, Milan
    Grujicic, Sandra Sipetic
    CURRENT PROBLEMS IN CANCER, 2021, 45 (06)
  • [9] Real-world outcomes of adjuvant immunotherapy candidates with upper tract urothelial carcinoma: results of a multicenter cohort study
    Kagawa, Hirokazu
    Urabe, Fumihiko
    Kiuchi, Yuria
    Katsumi, Kota
    Yamaguchi, Ryotaro
    Suhara, Yushi
    Yoshihara, Kentaro
    Goto, Yuma
    Sadakane, Ibuki
    Yata, Yuji
    Saito, Shun
    Kurawaki, Shiro
    Ajisaka, Shino
    Miyajima, Keiichiro
    Takahashi, Kazuhiro
    Iwatani, Kosuke
    Imai, Yu
    Sakanaka, Keigo
    Nakazono, Minoru
    Kurauchi, Takashi
    Kayano, Sotaro
    Onuma, Hajime
    Aikawa, Koichi
    Yanagisawa, Takafumi
    Tashiro, Kojiro
    Tsuzuki, Shunsuke
    Furuta, Akira
    Miki, Jun
    Kimura, Takahiro
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, 29 (01) : 55 - 63
  • [10] Real-world outcomes of adjuvant immunotherapy candidates with upper tract urothelial carcinoma: results of a multicenter cohort study
    Hirokazu Kagawa
    Fumihiko Urabe
    Yuria Kiuchi
    Kota Katsumi
    Ryotaro Yamaguchi
    Yushi Suhara
    Kentaro Yoshihara
    Yuma Goto
    Ibuki Sadakane
    Yuji Yata
    Shun Saito
    Shiro Kurawaki
    Shino Ajisaka
    Keiichiro Miyajima
    Kazuhiro Takahashi
    Kosuke Iwatani
    Yu Imai
    Keigo Sakanaka
    Minoru Nakazono
    Takashi Kurauchi
    Sotaro Kayano
    Hajime Onuma
    Koichi Aikawa
    Takafumi Yanagisawa
    Kojiro Tashiro
    Shunsuke Tsuzuki
    Akira Furuta
    Jun Miki
    Takahiro Kimura
    International Journal of Clinical Oncology, 2024, 29 : 55 - 63